MONDAY, Oct. 28, 2024 -- Empagliflozin continues to offer cardiorenal benefits for up to 12 months after discontinuation among patients with chronic...

FRIDAY, Nov. 1, 2024 -- Maintaining or initiating regular physical activity (PA) after a dementia diagnosis is associated with a reduced risk for...

FRIDAY, Nov. 1, 2024 -- Maintaining or initiating regular physical activity (PA) after a dementia diagnosis is associated with a reduced risk for...

FRIDAY, Nov. 1, 2024 -- For patients with type 2 diabetes mellitus, semaglutide is associated with a reduced risk for a first-time Alzheimer disease...

FRIDAY, Nov. 1, 2024 -- For patients with type 2 diabetes mellitus, semaglutide is associated with a reduced risk for a first-time Alzheimer disease...

Type 2 diabetes affects 1.2 million Australians and accounts for 85-90% of all diabetes cases. This chronic condition is characterised by high blood...

Glucagon-like peptide-1-receptor agonists (GLP-1RA) are medications that are increasingly prescribed for patients with type 2 diabetes and congestive...

FRIDAY, Nov. 1, 2024 -- Chronic kidney disease (CKD) cases and deaths in women surged worldwide between 1990 and 2021, according to a study presented...

THURSDAY, Oct. 24, 2024 -- Protracted low-dose exposure to ionizing radiation among radiation-monitored workers is associated with mortality due to...

Chronic kidney disease (CKD) cases among women have nearly tripled globally in the past three decades, marking a significant rise in this health...